Definitive Healthcare (NASDAQ:DH) Issues FY24 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $0.36-$0.38 for the period, compared to the consensus estimate of $0.38. The company issued revenue guidance of $255-261 million, compared to the consensus revenue estimate of $266.31 million. Definitive Healthcare also updated its Q2 guidance to $0.08-$0.09 EPS.

Analysts Set New Price Targets

Several research firms have recently weighed in on DH. Needham & Company LLC reissued a hold rating on shares of Definitive Healthcare in a research report on Wednesday. Deutsche Bank Aktiengesellschaft cut their price objective on Definitive Healthcare from $10.00 to $7.00 and set a hold rating on the stock in a research note on Thursday. Canaccord Genuity Group lowered their price target on Definitive Healthcare from $10.00 to $8.00 and set a hold rating for the company in a report on Wednesday. Barclays reduced their price objective on Definitive Healthcare from $11.00 to $7.00 and set an equal weight rating on the stock in a research note on Thursday. Finally, Stifel Nicolaus dropped their target price on shares of Definitive Healthcare from $11.00 to $9.50 and set a buy rating on the stock in a report on Wednesday. Nine equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, Definitive Healthcare currently has a consensus rating of Hold and a consensus price target of $9.94.

Definitive Healthcare Stock Performance

Definitive Healthcare stock traded up $0.03 during midday trading on Friday, reaching $5.20. 2,047,511 shares of the stock traded hands, compared to its average volume of 658,212. The firm has a fifty day moving average price of $7.61 and a two-hundred day moving average price of $8.27. Definitive Healthcare has a fifty-two week low of $4.38 and a fifty-two week high of $12.45. The firm has a market cap of $612.51 million, a price-to-earnings ratio of -2.90, a PEG ratio of 6.12 and a beta of 1.41. The company has a current ratio of 2.31, a quick ratio of 2.31 and a debt-to-equity ratio of 0.20.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). The business had revenue of $65.93 million during the quarter, compared to the consensus estimate of $66.01 million. Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. On average, equities research analysts forecast that Definitive Healthcare will post 0.11 earnings per share for the current year.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.